Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cascadian Therapeutics Inc (NASDAQ:CASC)

1.15
Delayed Data
As of 10:05am ET
 0.00 / 0.00%
Today’s Change
0.82
Today|||52-Week Range
3.89
-48.20%
Year-to-Date
6 Stocks that Seth Klarman Loves
Aug 24 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close1.15
Today’s open1.16
Day’s range1.15 - 1.19
Volume17,490
Average volume (3 months)914,339
Market cap$155.6M
Dividend yield--
Data as of 10:05am ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+46.88%
Earnings growth (this year)-41.18%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.30

Competitors

 Today’s
change
Today’s
% change
PRTOProteon Therapeutics...0.000.00%
CDXSCodexis Inc+0.02+0.47%
SNMXSenomyx Inc+0.07+1.71%
AVXLAnavex Life Sciences...+0.01+0.32%
Data as of 10:16am ET, 08/26/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$0.00
Annual profit (last year)-$32.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts

Partner Offers

Search for Jobs